Methods and compounds for improved immune cell therapy
EP3597211A1
Periostin compounds for the treatment of haematological complications
EP3292870A1
Fibronectin for use in the treatment of leukemia
AU2015276136A1
Car-expressing NK-92 cells as cell therapeutic agents
EP2614151A1
Interleukin 15 as selectable marker for gene transfer in lymphocytes
EP3115373A1
Chimeric antigen receptors with an optimized hinge region
EP2545070A1
Stat3 activation inhibitors
EP2060581A1
Scaffold proteins for recombinant peptide aptamers
EP1873251A1
Expression vector(s) for enhanced expression of a protein of interest in eukaryotic or prokaryotic host cells
DE102004034461A1
Gene Therapy of Solid Tumors by Retroviral Arenavirus Glycoprotein-Pseudotyped Vectors
EP1426055A1
Targeted protein degradation vehicles (tpdvs), nucleic acid constructs encoding them and their use
EP1170008A1
Valproic acid and derivatives thereof as histone deacetylase inhibitors
DE4329177A1
Cloning of a new member of the serine threonine kinase family
DE4239817A1
New protein tyrosine kinase and related nucleic acid - vectors, transformed cells, etc., useful for diagnosis and treatment of tumours
DE4233782A1
Human embryonal kinase 2-receptor protein - useful in tumour diagnosis and therapy
DE4228787A1
New HIV-1 virus isolates of a subtype, vaccines against HIV-1 virus infections of this subtype and process for their preparation, use of the HIV-1 virus isolates
DE3934366A1
VACCINE FOR PROTECTION AGAINST HIV VIRUS INFECTIONS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A DIAGNOSTIC AND IMMUNOTHERAPEUTIC
DE1032001B
Device for the electrophoretic decomposition of substance mixtures into components of different migration speeds and method for using this device
